Fosphenytoin Sodium
NDC Package 0703-7101-04

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Fosphenytoin Sodium is a . Marketed by Teva Parenteral Medicines, Inc., this product is identified by NDC 0703-7101 and is authorized under FDA application ANDA076886.

Identification & Billing

NDC Package Code
0703-7101-04
Package Description
25 VIAL in 1 TRAY / 2 mL in 1 VIAL (0703-7101-01)
Product Code
0703-7101
11-Digit Billing Format
00703710104

Clinical Specifications

Proprietary Name
Fosphenytoin Sodium
Dosage Form
-

Regulatory & Marketing

Labeler Name
Teva Parenteral Medicines, Inc.
FDA Application #
ANDA076886
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
09-14-2007
End Marketing Date
08-31-2011
Listing Expiration
08-31-2011
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0703-7101-04 identifies a specific commercial package of 25 vial in 1 tray / 2 ml in 1 vial (0703-7101-01) of Fosphenytoin Sodium, labeled by Teva Parenteral Medicines, Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Teva Parenteral Medicines, Inc. on September 14, 2007. The current certification is valid through August 31, 2011.

How is this Teva Parenteral Medicines, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00703710104. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0703-7101-04
11-Digit CMS (5-4-2)
00703-7101-04

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.